Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement
News|Slideshows|August 29, 2025

August Pharmaceutical Industry Movers & Shakers

Author(s)Don Tracy, Associate Editor

A monthly roundup of business and people news in the pharmaceutical industry.

Advertisement

Advertisement
Corporate Communications

Related Content

Advertisement
Ryan Last

Realistic Timelines for Pharma Manufacturing Reshoring

ByMike Hollan,Ryan Last
July 2nd 2026
Pharmaceutical executive daily

Pharmaceutical Executive Daily: The Medicare GLP-1 Bridge

ByNicholas Jacobus
July 1st 2026
stock.adobe.com GLP-1

Wegovy Now Available to Eligible Medicare Beneficiaries Through Medicare GLP-1 Bridge

ByNicholas Jacobus
July 1st 2026
stock.adobe.com clinical trials

AlzeCure Pharma Enters $2.2 Billion Licensing and Collaboration Agreement with QuantumCell ApS

ByNicholas Jacobus
July 1st 2026
Ryan Last

Targeted Onshoring's Impact on Domestic Pharma Manufacturing

ByMike Hollan,Ryan Last
July 1st 2026
Advertisement
Advertisement

Trending on PharmExec

1

U.S. House Committee Investigating Drugmakers Involved in China Drug Trials: Report

2

Realistic Timelines for Pharma Manufacturing Reshoring

3

Wegovy Now Available to Eligible Medicare Beneficiaries Through Medicare GLP-1 Bridge

4

AlzeCure Pharma Enters $2.2 Billion Licensing and Collaboration Agreement with QuantumCell ApS

5

Preparing for the July 31 Pharma Tariff Deadline

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us